skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Explore Research Products in the PAR
It may take a few hours for recently added research products to appear in PAR search results.


  • Home
  • Search Results
  • Page 1 of 17

Search for: All records

Creators/Authors contains: "Todd, J"

Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher. Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?

Some links on this page may take you to non-federal websites. Their policies may differ from this site.

  1. ; ; ; ; ; ; ; ; (, Scientific Reports)
    Free, publicly-accessible full text available December 1, 2026
  2. ; ; ; ; (, Springer Nature Switzerland)
    Free, publicly-accessible full text available September 1, 2026
  3. (, ASEE)
    Free, publicly-accessible full text available June 23, 2026
  4. ; ; ; ; ; ; ; ; ; ; et al (, Communications Biology)
    Current methods for producing cardiomyocytes from human induced pluripotent stem cells (hiPSCs) using 2D monolayer differentiation are often hampered by batch-to-batch variability and inef!cient puri!cation processes. Here, we introduce CM-AI, a novel arti!cial intelligence-guided laser cell processing platform designed for rapid, label-free puri!cation of hiPSC-derived cardiomyocytes (hiPSC-CMs). This approach signi!cantly reduces processing time without the need for chronic metabolic selection or antibody-based sorting. By integrating real-time cellular morphology analysis and targeted laser ablation, CM-AI selectively removes non-cardiomyocyte populations with high precision. This streamlined process preserves cardiomyocyte viability and function, offering a scalable and ef!cient solution for cardiac regenerative medicine, disease modeling, and drug disco 
    more » « less
    Free, publicly-accessible full text available December 1, 2026
  5. ; ; (, ASEE)
    Free, publicly-accessible full text available June 23, 2026
  6. ; ; (, ASEE)
    Free, publicly-accessible full text available June 23, 2026
  7. ; ; ; ; ; (, Journal of Biological Chemistry)
    Free, publicly-accessible full text available June 1, 2026
  8. ; ; (, IEEE)
    Free, publicly-accessible full text available March 22, 2026
  9. ; ; ; (, IEEE)
    Free, publicly-accessible full text available March 22, 2026
  10. ; ; ; (, IEEE)
    Free, publicly-accessible full text available March 22, 2026